Advertisement
Advertisement
CING
Cingulate Inc. Common Stock
6.36
USDSponsored
-0.38
-5.66%
Mar 25, 15:59 UTC -4
Closed
Pre-Market
6.33
-0.03
-0.41%
CING Earnings Reports
Positive Surprise Ratio
CING beat 7 of 17 last estimates.
41%
Next Report
Date of Next Report
--
Estimate for Q-- -- (Revenue/ EPS)
--
/--
Implied change from Q4 25 (Revenue/ EPS)
--
/--
Implied change from Q-- -- (Revenue/ EPS)
--
/--
Cingulate Inc. Common Stock earnings per share and revenue
On Mar 18, 2026, CING reported earnings of -0.93 USD per share (EPS) for Q4 25, missing the estimate of -0.64 USD, resulting in a -44.59% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -31.05% price change (close before vs. close after earnings).
Looking ahead to -- --, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Precigen, Inc. Common Stock
Report Date
Mar 25, 2026 For Q4 25
Estimate
-$0.08
Actual
-$0.01
Surprise
+88.24%
Absci Corporation Common Stock
Report Date
Mar 24, 2026 For Q4 25
Estimate
-$0.19
Actual
-$0.23
Surprise
-16.04%
Candel Therapeutics, Inc. Common Stock
Report Date
Mar 26, 2026 For Q4 25
Estimate
-$0.25
Actual
-$0.54
Surprise
-115.31%
LENZ Therapeutics, Inc. Common Stock
Report Date
Mar 24, 2026 For Q4 25
Estimate
-$0.99
Actual
-$1.15
Surprise
-17.10%
Fennec Pharmaceuticals Inc. Common Stock
Report Date
Mar 24, 2026 For Q4 25
Estimate
$0.03
Actual
-$0.11
Surprise
-408.12%
Equillium, Inc. Common Stock
Report Date
Mar 25, 2026 For Q4 25
Estimate
-$0.06
Actual
-$0.04
Surprise
+35.28%
MaxCyte, Inc. Common Stock
Report Date
Mar 24, 2026 For Q4 25
Estimate
-$0.08
Actual
-$0.06
Surprise
+26.47%
Celcuity Inc. Common Stock
Report Date
Mar 25, 2026 For Q4 25
Estimate
-$1.06
Actual
-$0.97
Surprise
+8.72%
Dyadic International, Inc.
Report Date
Mar 25, 2026 For Q4 25
Estimate
-$0.04
Actual
-$0.06
Surprise
-30.72%
TELA Bio, Inc. Common Stock
Report Date
Mar 24, 2026 For Q4 25
Estimate
-$0.18
Actual
-$0.16
Surprise
+14.12%
FAQ
What were Cingulate Inc. Common Stock's earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, Cingulate Inc. Common Stock reported EPS of -$0.93, missing estimates by -44.59%, and revenue of $0.00, 0% as expectations.
How did the market react to Cingulate Inc. Common Stock's Q4 2025 earnings?
The stock price moved down -31.05%, changed from $11.66 before the earnings release to $8.04 the day after.
When is Cingulate Inc. Common Stock expected to report next?
The next earning report is scheduled for --.
What are the forecasts for Cingulate Inc. Common Stock's next earnings report?
Based on --
analysts, Cingulate Inc. Common Stock is expected to report EPS of -- and revenue of -- for Q-- --.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement